232 related articles for article (PubMed ID: 1496982)
1. Neurofibromatosis type 2 appears to be a genetically homogeneous disease.
Narod SA; Parry DM; Parboosingh J; Lenoir GM; Ruttledge M; Fischer G; Eldridge R; Martuza RL; Frontali M; Haines J
Am J Hum Genet; 1992 Sep; 51(3):486-96. PubMed ID: 1496982
[TBL] [Abstract][Full Text] [Related]
2. Analysis of chromosome 22 deletions in neurofibromatosis type 2-related tumors.
Wolff RK; Frazer KA; Jackler RK; Lanser MJ; Pitts LH; Cox DR
Am J Hum Genet; 1992 Sep; 51(3):478-85. PubMed ID: 1496981
[TBL] [Abstract][Full Text] [Related]
3. Germline deletion in a neurofibromatosis type 2 kindred inactivates the NF2 gene and a candidate meningioma locus.
Sanson M; Marineau C; Desmaze C; Lutchman M; Ruttledge M; Baron C; Narod S; Delattre O; Lenoir G; Thomas G
Hum Mol Genet; 1993 Aug; 2(8):1215-20. PubMed ID: 8401504
[TBL] [Abstract][Full Text] [Related]
4. Presymptomatic diagnosis for neurofibromatosis 2 with chromosome 22 markers.
Ruttledge MH; Narod SA; Dumanski JP; Parry DM; Eldridge R; Wertelecki W; Parboosingh J; Faucher MC; Lenoir GM; Collins VP
Neurology; 1993 Sep; 43(9):1753-60. PubMed ID: 8414026
[TBL] [Abstract][Full Text] [Related]
5. Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors.
Ng HK; Lau KM; Tse JY; Lo KW; Wong JH; Poon WS; Huang DP
Neurosurgery; 1995 Oct; 37(4):764-73. PubMed ID: 8559307
[TBL] [Abstract][Full Text] [Related]
6. Presymptomatic DNA and MRI diagnosis of neurofibromatosis 2 with mild clinical course in an extended pedigree.
Sainio M; Strachan T; Blomstedt G; Salonen O; Setälä K; Palotie A; Palo J; Pyykkö I; Peltonen L; Jääskeläinen J
Neurology; 1995 Jul; 45(7):1314-22. PubMed ID: 7617190
[TBL] [Abstract][Full Text] [Related]
7. Severe phenotype of neurofibromatosis type 2 in a patient with a 7.4-MB constitutional deletion on chromosome 22: possible localization of a neurofibromatosis type 2 modifier gene?
Bruder CE; Ichimura K; Blennow E; Ikeuchi T; Yamaguchi T; Yuasa Y; Collins VP; Dumanski JP
Genes Chromosomes Cancer; 1999 Jun; 25(2):184-90. PubMed ID: 10338003
[TBL] [Abstract][Full Text] [Related]
8. Clinical manifestations of mutations in the neurofibromatosis type 2 gene in vestibular schwannomas (acoustic neuromas).
Welling DB
Laryngoscope; 1998 Feb; 108(2):178-89. PubMed ID: 9473065
[TBL] [Abstract][Full Text] [Related]
9. Progress toward the isolation and characterization of the genes causing neurofibromatosis.
Menon AG; Gusella JF; Seizinger BR
Brain Pathol; 1990 Sep; 1(1):33-40. PubMed ID: 1669691
[TBL] [Abstract][Full Text] [Related]
10. Mapping the breakpoint of a constitutional translocation on chromosome 22 in a patient with NF2.
Arai E; Tokino T; Imai T; Inazawa J; Ikeuchi T; Tonomura A; Nakamura Y
Genes Chromosomes Cancer; 1993 Apr; 6(4):235-8. PubMed ID: 7685627
[TBL] [Abstract][Full Text] [Related]
11. Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas.
Lekanne Deprez RH; Bianchi AB; Groen NA; Seizinger BR; Hagemeijer A; van Drunen E; Bootsma D; Koper JW; Avezaat CJ; Kley N
Am J Hum Genet; 1994 Jun; 54(6):1022-9. PubMed ID: 7911002
[TBL] [Abstract][Full Text] [Related]
12. Linkage analysis of von Recklinghausen neurofibromatosis to DNA markers on chromosome 17.
Diehl SR; Boehnke M; Erickson RP; Baxter AB; Bruce MA; Lieberman JL; Platt DJ; Ploughman LM; Seiler KA; Sweet AM
Genomics; 1987 Dec; 1(4):361-3. PubMed ID: 2896631
[TBL] [Abstract][Full Text] [Related]
13. A group of schwannomas with interstitial deletions on 22q located outside the NF2 locus shows no detectable mutations in the NF2 gene.
Bruder CE; Ichimura K; Tingby O; Hirakawa K; Komatsuzaki A; Tamura A; Yuasa Y; Collins VP; Dumanski JP
Hum Genet; 1999 May; 104(5):418-24. PubMed ID: 10394935
[TBL] [Abstract][Full Text] [Related]
14. Flanking markers bracket the neurofibromatosis type 2 (NF2) gene on chromosome 22.
Rouleau GA; Seizinger BR; Wertelecki W; Haines JL; Superneau DW; Martuza RL; Gusella JF
Am J Hum Genet; 1990 Feb; 46(2):323-8. PubMed ID: 2105641
[TBL] [Abstract][Full Text] [Related]
15. Highly polymorphic dinucleotide repeat at the NF2 gene.
Bourn D; Strachan T
Hum Genet; 1995 Jun; 95(6):712. PubMed ID: 7789960
[TBL] [Abstract][Full Text] [Related]
16. Neurofibromatosis type 2 and von Hippel-Lindau disease: from gene cloning to function.
Kley N; Whaley J; Seizinger BR
Glia; 1995 Nov; 15(3):297-307. PubMed ID: 8586465
[TBL] [Abstract][Full Text] [Related]
17. DNA diagnosis of neurofibromatosis 2. Altered coding sequence of the merlin tumor suppressor in an extended pedigree.
MacCollin M; Mohney T; Trofatter J; Wertelecki W; Ramesh V; Gusella J
JAMA; 1993 Nov; 270(19):2316-20. PubMed ID: 8230593
[TBL] [Abstract][Full Text] [Related]
18. The mouse neurofibromatosis type 2 gene maps to chromosome 11.
Claudio JO; Malo D; Rouleau GA
Genomics; 1994 May; 21(2):437-9. PubMed ID: 8088840
[TBL] [Abstract][Full Text] [Related]
19. Familial meningioma is not allelic to neurofibromatosis 2.
Pulst SM; Rouleau GA; Marineau C; Fain P; Sieb JP
Neurology; 1993 Oct; 43(10):2096-8. PubMed ID: 8413972
[TBL] [Abstract][Full Text] [Related]
20. Neurofibromatosis type 2: genetic and clinical features.
Evans DG
Ear Nose Throat J; 1999 Feb; 78(2):97-100. PubMed ID: 10089694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
